Long-term functional evaluation of the treated kidney in a prospective series of patients who underwent laparoscopic partial nephrectomy for small renal tumors. by Porpiglia, Francesco et al.
 
 
This Accepted Author Manuscript (AAM) is copyrighted and published by Elsevier. It is posted here 
by agreement between Elsevier and the University of Turin. Changes resulting from the publishing 
process - such as editing, corrections, structural formatting, and other quality control mechanisms - 
may not be reflected in this version of the text. The definitive version of the text was subsequently 
published in  
 
 
 
Long-term functional evaluation of the treated kidney in a 
prospective series of patients who underwent laparoscopic 
partial nephrectomy for small renal tumors 
 
Volume: 62 
Issue:1 
Pages: 130-135 
DOI:10.1016/j.eururo.2012.02.001 
Published: JUL 2012 
 
You may download, copy and otherwise use the AAM for non-commercial purposes provided that 
your license is limited by the following restrictions: 
 
(1) You may use this AAM for non-commercial purposes only under the terms of the CC-BY-NC-ND 
license.  
(2) The integrity of the work and identification of the author, copyright owner, and publisher must be 
preserved in any copy.  
(3) You must attribute this AAM in the following format: Creative Commons BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/deed.en) 
DOI:10.1016/j.eururo.2012.02.001 
Abstract 
Background 
Renal scintigraphy may allow long-term monitoring of ischemic damage after partial nephrectomy (PN). 
Objective 
Evaluate use of renal scintigraphy for evaluating long-term effects of warm ischemia on renal function in 
patients with a normal contralateral kidney. 
Design, setting, and participants 
We prospectively examined kidney function of 54 patients who underwent laparoscopic PN (LPN). 
Minimum follow-up time was 4 yr. 
Intervention 
LPN was performed with warm ischemia by transperitoneal or retroperitoneal approach. 
Measurements 
Demographic, perioperative, and pathologic data and postoperative complications were registered. Split 
renal function (SRF) and effective renal plasma flow (ERPF) were evaluated by renal scintigraphy 
preoperatively, at 3 and 12 mo postoperatively, then yearly. Baseline weighted differentials (b-WDs) of 
both SRF and ERPF in the affected kidney were calculated between baseline condition and every time 
point. Multivariate linear regression was used to find independent variables for increased b-WDs at 3 and 
48 mo. P values <0.05 were considered significant. 
Results and limitations 
The SRF and ERPF of kidneys treated by LPN decreased significantly at month 3 and subsequently 
remained stable through the duration of follow-up. Conversely, neither serum creatinine nor estimated 
glomerular filtration rate changed significantly during follow-up. The regression model showed statistical 
significance at month 3 for warm ischemia time (WIT) and age, whereas at 48 mo, statistical significance 
was reached by WIT alone. No new onset of cardiovascular disease was registered. No evidence of local 
recurrence was recorded with computed tomography scan. Our study may be underpowered due to small 
sample size; however, this is one of the largest long-term prospective series using renal scintigraphy to 
evaluate the renal function after LPN. 
Conclusions 
WIT contributes to irreversible kidney damage observed at month 3 that does not appear to worsen. 
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1. Introduction 
Elective partial nephrectomy (PN) is considered the gold standard of treatment for renal tumors ≤7 cm [1]. 
Most surgeons prefer the use of vascular clamping to improve visualization of the tumor limits, facilitating 
complete tumor resection and minimizing the risk of positive surgical margin (PSM). A bloodless field 
allows precise surgical closure of the collecting system and parenchymal defects [2]. The most common 
method used to perform ischemia is clamping of the renal artery with or without the renal vein (warm 
ischemia). Warm ischemia time (WIT) was identified as the most important surgery-related factor affecting 
renal function in patients who underwent PN [3]. Moreover, ischemic damage and postischemic renal 
failure may be involved in hypertension development and cardiovascular diseases (CVDs) [4]. 
Although every minute counts when the renal hilum is clamped [5], data suggest that safe WIT ranges 
between 20 and 25 min [5], [6] and [7]. 
Few studies have evaluated the long-term effect of WIT on treated kidney function in patients who 
underwent elective PN [8], [9], [10] and [11]. Moreover, most of the available studies evaluated kidney 
function using serum creatinine (SCr) and/or estimated glomerular filtration rate (eGFR), underestimating 
the importance of the normal contralateral kidney in masking biochemical changes. Renal scintigraphy 
(RS) is the only method that allows clinicians to quantify real changes in the amount of renal-function loss 
of the treated kidney [12] and [13]. To contribute to this discussion, we planned the present prospective 
study with two aims. The first was to evaluate the long-term effect of WIT on renal function, using split 
renal function (SRF) and effective renal plasmatic flow (ERPF) estimated by radionuclide technetium Tc 
99m–mercaptoacetyl-triglycine (99mTc-MAG-3) RS, in a series of patients who underwent elective LPN for 
renal tumors. The second aim was to identify the predictors of renal damage following LPN. 
2. Patients and methods 
We prospectively enrolled all patients who underwent LPN between July 2004 and December 2007. All 
patients signed a written informed consent approved by the ethics committee of our center. Abdominal 
computed tomography (CT) scan and RS using radionuclide 99mTc-MAG-3 were performed preoperatively 
in every patient. 
2.1. Inclusion criteria 
We enrolled all patient candidates for LPN of renal tumors ≤4 cm, with baseline eGFR (modification of diet 
in renal disease [MDRD] formula) ≥60 ml/min [4] (stage I/II chronic kidney disease [CKD] according to the 
Kidney Disease Outcomes Quality Initiative), and baseline SRF ranging from 45% to 55% in the treated 
kidney. Only patients with minimum follow-up of 4 yr were included in the analysis. 
2.2. Exclusion criteria  
Patients with a solitary or horseshoe-shaped kidney and/or kidney scars at the preoperative CT scan were 
excluded. In addition, patients who experienced complications potentially affecting kidney function, such as 
significant bleeding (causing severe hypotension), urinary fistula, kidney infection, or any other condition 
different from the intervention itself were excluded from the analysis. 
2.3. Intervention 
All patients underwent LPN performed by a single surgeon using the technique described previously [14]. 
In all cases, the renal artery alone was clamped with a bulldog clamp and declamped at the end of the 
renal parenchyma reconstruction. 
2.4. Measurements 
For each patient, we prospectively collected the following variables in a dedicated database: demographic 
data including comorbidities classified according to Charlson comorbidity index (CCI) [15], and clinical 
tumor size, side, and location according to the RENAL nephrometry score [16]; perioperative data; 
pathologic data; and postoperative complications classified according to the Clavien system [17]. 
Moreover, CCI and new onset of CVDs were recorded at each time point. Body mass index (BMI) also was 
recorded to assess whether LPN influenced patients’ body build, a possible confounder of eGFR 
assessment [13]. 
Patients with a final diagnosis of renal cell carcinoma were generally observed every 3 to 4 mo for the first 
year after LPN and every 6 mo from the second through the fifth years. Oncologic follow-up consisted of a 
history, a physical examination, and an abdominal evaluation using ultrasound or CT scan. Elective bone 
scan, chest CT, and magnetic resonance imaging were performed when clinically indicated. 
2.5. Evaluation of renal function 
SCr and eGFR (abbreviated MDRD formula) were assessed by serial measurements; SRF and ERPF 
were evaluated by 99mTc-MAG-3 RS. All renal scintigraphies were performed at our institution and read by a 
dedicated nuclear-medicine doctor. The measures were conducted preoperatively, at the 3rd and 12th 
postoperative months (POMs), and then yearly for a minimum of 4 yr. 
A normal range does not exist for SRF and ERPF calculated by RS and there is variability among patients, 
so we created a new variable called baseline weighted differential (b-WD) that represented the percentage 
of loss of SRF or ERPF, considering the baseline value. This variable was used in statistical analysis to 
eliminate the possible confounder of a different patient's scintigraphic baseline value in the preoperative 
setting, with 1) b-WD of SRF = (n POM SRF − baseline SRF)/baseline SRF, where n = 3, 12, 24, 36, and 
48, respectively, and 2) b-WD of ERPF = (n POM ERPF − baseline ERPF)/baseline ERPF, where n = 3, 
12, 24, 36, and 48, respectively. 
2.6. Pathology assessment 
A dedicated uropathologist analyzed fresh-tissue specimens from the operative room and assigned 
extension of the primary tumor according to the 2009 version of TNM classification [18]. After fixation in a 
10% formalin solution, all specimens were step-sectioned at 5-mm intervals and the entire specimen was 
analyzed, including the distance between the inked margin and the tumor, with the aim of assigning the 
mean value of the thickness of the peritumoral healthy tissue [19]. Histologic subtypes and nuclear grade 
were defined according to the World Health Organization classification [20] and to the Fuhrman 
classification [21], respectively. PSM was defined as cancer cells at the level of inked parenchymal 
excision surface [19]. 
2.7. Statistical analysis 
Means and standard deviations were used to report continuous variables. Frequencies and proportions 
were used for categoric variables. The means of continuous variables were compared using the student t 
test after verifying that variables to be analyzed were approximately normally distributed. Analysis of 
variance (ANOVA) was used to compare the means of more than two groups. Multivariable linear 
regression analysis was used to identify independent predictors of SRF and ERPF b-WD changes. All 
variables potentially influencing postoperative renal function were included in the models. 
All tests were two sided, and p values <0.05 were considered significant. All statistical analyses were 
performed using Statistic 6 (Statsoft Inc.; Tulsa, OK, USA). 
3. Results 
Seventy-five patients were enrolled during the specified period. Three patients were excluded: One patient 
was not analyzed due to horseshoe-shaped kidney, and two patients had early postoperative 
complications (one had acute bleeding causing severe hypotension and one had a urinary fistula) and 
were excluded from undergoing following scintigraphic controls. Of 72 analyzable patients, 54 reached the 
minimum follow-up of 4 yr and were considered the population of the study. Table 1 shows the 
demographic, perioperative, and pathologic findings of these patients. 
Observed postoperative complications (n = 4; 7.4%) were grade 1–2, according to Clavien classification. 
Specifically, two patients required transfusion for postoperative bleeding, one patient was medically treated 
for pneumonia, and one patient was treated for pleural effusion. During oncologic follow-up, no patient 
showed local recurrence or distant progression. No patient died during the follow-up period. 
Neither SCr nor eGFR changed significantly during follow-up (Table 2). Conversely, either the mean value 
or the value at 3 mo after LPN, both for SFR (48.05 ± 4.33 vs 44.76 ± 2.40; p = 0.0030) ( Fig. 1a) and 
ERPF (182.70 ± 34.01 vs 153.54 ± 42.34; p = 0.0001) ( Fig. 1b) of the operated kidney decreased 
significantly in comparison with their baseline values. This decrease remained stable for follow-up 
measurements. Accordingly, no differences were found among the five postoperative functional 
measurements ( Table 2). Moreover, SRF b-WD ( Fig. 1c) and ERPF b-WD ( Fig. 1d) were comparable at 
every time point. 
At multivariable analysis (Table 3), age (p = 0.03) and WIT (p = 0.03) turned out to be independent 
predictors of SRF b-WD increasing 3 mo after LPN. Only WIT was a predictor of ERPF b-WD increasing (p 
= 0.0210) 3 mo after LPN, while 4 yr after PN, only WIT predicted ERPF b-WD increasing. Conversely, no 
risk factor for worsening of SRF b-WD was detected. 
BMI and CCI did not change statistically at the measured time points. No new onset of CVDs was 
registered. 
4. Discussion 
Many studies evaluating functional outcomes after LPN have been performed in patients either with a 
solitary kidney or with a normal contralateral kidney. These studies used different markers of kidney 
function, mainly aiming to identify a safe WIT cut-off. Results have varied based on the individual 
experience of the surgeons involved, the patient population size, and the markers used. Although some 
authors suggested that every minute counts when the renal hilum is clamped [5], the majority of these 
studies indicate a safe WIT cut-off range between 20 and 25 min [5], [6] and [7]. In previous studies, the 
25-min WIT cut-off appeared to be the most clinically helpful [5], [22] and [23]. 
It is well known that warm ischemia (WI) causes a direct hypoxic injury to the kidney [24], but the natural 
history of this recorded damage is not well understood. The aim of the present prospective study was to 
better elucidate this natural history. 
We analyzed 54 patients who underwent LPN performed with WI and we evaluated renal function by using 
SCr, eGFR and, specifically, RS. This nuclear-medicine technique has been used in various studies in the 
urologic literature [12], [13] and [22] to estimate renal damage of operated kidney after intervention by 
using SRF and ERPF. 
All analyzed patients reached a minimum follow-up time of 4 yr and we considered this length of follow-up 
sufficient to study the history of renal function following LPN. 
Our results confirmed that SCr and derived measures have low sensitivity for evaluating kidney damage in 
cases presenting normal or moderately reduced kidney function (CKD stage I/II) at follow-up. In contrast, 
by using SRF and ERPF estimated by RS, we recorded loss of renal function at the third POM with respect 
to baseline. This loss remained stable over time as confirmed by follow-up measurements of SRF and 
ERPF and b-WD variables. Thus we can state that major loss of kidney function is recorded by the third 
POM, whereas kidney function remains stable over further follow-up. These findings may suggest that 
future studies of early kidney damage should focus on the results of RS and should accurately record SRF 
and ERPF data. 
Confirming literature findings, the multivariable linear regression analysis evaluating our data at 
postoperative months 3 and 48 indicated that WIT plays a crucial role in predicting worsening of 
scintigraphic parameters after LPN. Moreover, age was statistically significant on third-POM analysis 
based on SRF b-WD, confirming that unmodifiable parameters also have an important impact on renal 
function [25]. In the present study, all other parameters demonstrated no statistical significance in 
predicting kidney function impairment over the course of a series of long-term follow-ups. 
One of the concerns with long-term kidney damage is that pathogenic insult (eg, WIT) may trigger a 
mechanism of renal damage maintained by cytokines produced by cells of the distal tubuli that are able to 
exacerbate the inflammatory response, stimulating further injury [24] and [26]. This is not supported by our 
findings. On the contrary, our results support the hypothesis of limited damage, remaining stable over time. 
With regard to comorbidities, we recorded neither an increase in CCI nor a new onset of CVDs with 
respect to the baseline conditions. According to our data at the fourth postoperative year, we can state that 
the limited injury to kidney parenchyma following LPN is not sufficient to trigger mechanisms involved in 
hypertension development and following CVDs or comorbidities related to postischemic renal failure. 
We did not record any local recurrence or evidence of new-onset parenchymal scars among patients who 
had a histologic diagnosis of malignant tumor and underwent CT scan during follow-up. The absence of 
any parenchymal scar indirectly confirmed that there is not a fibrogenic response to ischemia and may 
suggest that there is not progressive involvement of the whole parenchyma. 
5. Conclusions 
In patients who undergo LPN performed with WI, the majority of renal damage detected by RS is recorded 
within the third POM without further worsening over time. WI seems to be the most important independent 
variable for predicting renal damage and surgeons should make every effort to minimize WI intervals. 
Moreover, it seems that renal ischemia does not trigger any mechanism leading to new onset of 
morbidities after LPN. 
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